pharma · Ovarian Cancer · Breast Cancer · ZNTL
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
10275 Science Center Dr, Suite 200, San Diego, California 92121, US HQ
123 Employees
Public company Type
ZNTL · NYSE Ticker
Company details
- Status
- Public
- HQ
- 10275 Science Center Dr, Suite 200, San Diego, California 92121, US
- Employees
- 123
- Programs
- 14
- Drugs
- 4
- Patents
- 0
Zentalis Pharmaceuticals patents
0 pharmaceutical patents indexed for Zentalis Pharmaceuticals. 0 expire within 24 months.
Zentalis Pharmaceuticals has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Zentalis Pharmaceuticals have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Zentalis Pharmaceuticals patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.